Deactivating cardioverter defibrillators near the end of life

BMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f558 (Published 30 January 2013)
Cite this as: BMJ 2013;346:f558

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

When US researchers surveyed 95 adults with implantable cardioverter defibrillators, 67 (71%) said they would consider deactivating the device when approaching the end of life. Responses to a series of scenarios varied between …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL